Bio-Rad Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,700
Employees7,700
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,700
Employees7,700

BIO Key Statistics

Market cap
8.13B
Market cap8.13B
Price-Earnings ratio
-12.40
Price-Earnings ratio-12.40
Dividend yield
Dividend yield
Average volume
151.83K
Average volume151.83K
High today
$304.91
High today$304.91
Low today
$298.74
Low today$298.74
Open price
$298.74
Open price$298.74
Volume
179.52K
Volume179.52K
52 Week high
$373.69
52 Week high$373.69
52 Week low
$211.43
52 Week low$211.43

Stock Snapshot

As of today, Bio-Rad Laboratories(BIO) shares are valued at $301.28. The company's market cap stands at 8.13B, with a P/E ratio of -12.40.

On 2025-12-17, Bio-Rad Laboratories(BIO) stock traded between a low of $298.74 and a high of $304.91. Shares are currently priced at $301.28, which is +0.8% above the low and -1.2% below the high.

The Bio-Rad Laboratories(BIO)'s current trading volume is 179.52K, compared to an average daily volume of 151.83K.

During the past year, Bio-Rad Laboratories(BIO) stock moved between $211.43 at its lowest and $373.69 at its peak.

During the past year, Bio-Rad Laboratories(BIO) stock moved between $211.43 at its lowest and $373.69 at its peak.

BIO News

Simply Wall St 2d
Is Bio-Rad Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics?

Earlier this month, Bio-Rad Laboratories participated in the Antibody Engineering & Therapeutics conference in San Diego, where Technical Sales Specialist Birth...

Is Bio-Rad Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics?

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.